Search results for: 'devic learning interface future of ai technician insights'
- Related search terms
- future of the us amp eu5 critical care markets preparing ventilator amp patient monitoring ecosystem players for success after a
- insights global defense market
- future of ksa logistics market dect 2021
- Insights for CISOs: The Transition to Quantum-Safe
- devic 01 00 00 00
-
17 Mar 2015  |  Global  |  Market Research
Analysis of the Global Diabetes Drug Delivery Market
Future Options for End Users
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Mar 2016  |  Global  |  Technology Research
Next Generation Diabetes Therapy and Drug Delivery Technologies
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Jul 2012  |  Europe  |  Market Research
European Diabetes Diagnostics Market
Growing Diabetes Prevalence Drives Demand
The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...
$4,950.00
Special Price $3,712.50 save 25 %